Non-Opioid Pain Treatment Market - 2024-2031

January 2024 | 51 pages | ID: NE539095118AEN
DataM Intelligence

Abstracts

Non-Opioid Pain Treatment Marketis is growing with a CAGR of 8.00% during the forecast period 2026-2035.

The Non-Opioid Pain Treatment Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned researchers harness advanced data analytics and strategic foresight to deliver unparalleled market intelligence. This insightful report meticulously explores the competitive landscape, profiling key players and their forward-thinking innovations in product development, pricing strategies, financial metrics, and global expansion initiatives. By uncovering the driving forces, market dynamics, and disruptive trends shaping the future, this research equips industry stakeholders with the actionable insights needed to make informed decisions in an increasingly dynamic and competitive environment.

A Non-Opioid Pain Treatment Market is a data-driven software solution that collects, integrates, analyzes, and visualizes customer data across various touchpoints to generate actionable insights. These platforms help businesses understand customer behaviors, preferences, and purchasing patterns in real time, enabling personalized marketing, enhanced customer engagement, and data-driven decision-making.

By Drug Type

• NSAIDs
• Corticosteriods
• Medical Cannabis Treatment
• Menthol-Containing Treatment
• Others

By Application

• Orthopedic and Musculoskeletal Pain
• Neuropathic Pain
• Cancer Pain
• Other Pain

Regional Analysis for Non-Opioid Pain Treatment Market:

• North America (U.S., Canada, Mexico)
• Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
• Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
• South America (Colombia, Brazil, Argentina, Rest of South America)
• Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

This Report Covers:

• Go-to-market Strategy.
• Neutral perspective on the market performance.
• Development trends, competitive landscape analysis, supply side analysis, demand side analysis, year-on-year growth, competitive benchmarking, vendor identification, and other significant analysis, as well as development status.
• Customized regional/country reports as per request and country level analysis.
• Potential & niche segments and regions exhibiting promising growth covered.
• Analysis of Market Size (historical and forecast), Total Addressable Market (TAM), Serviceable Available Market (SAM), Serviceable Obtainable Market (SOM), Market Growth, Technological Trends, Market Share, Market Dynamics, Competitive Landscape and Major Players (Innovators, Start-ups, Laggard, and Pioneer).

Research Process:

Both primary and secondary data sources have been used in the global Non-Opioid Pain Treatment Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.

Contents

1. METHODOLOGY AND SCOPE

1.1. Research Methodology
1.2. Research Objective and Scope of the Report

2. MARKET DEFINITION AND OVERVIEW

3. EXECUTIVE SUMMARY

3.1. Market Snippet by Drug Type
3.2. Market Snippet by Application
3.3. Market Snippet by Region
3.4. DataM CLO Scenario

4. MARKET DYNAMICS

4.1. Market Impacting Factors
  4.1.1. Drivers
    4.1.1.1. Rising geriatric population
    4.1.1.2. The rise in incidences of chronic pain
    4.1.1.3. Increase in the opioid misuse
    4.1.1.4. Robust pipeline
  4.1.2. Restraints
    4.1.2.1. Lack of awareness among common
    4.1.2.2. The abundance of counterfeit products
    4.1.2.3. No long term efficiency
  4.1.3. Opportunity
  4.1.4. Impact Analysis

5. INDUSTRY ANALYSIS

5.1. Porter's Five Forces Analysis
5.2. Supply Chain Analysis
5.3. Regulatory Analysis
5.4. Epidemiology

6. BY DRUG TYPE

6.1. Introduction
6.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Drug Type
6.3. Market Attractiveness Index, By Drug Type
6.4. NSAIDs
  6.4.1. Introduction
  6.4.2. Market Size Analysis, and Y-o-Y Growth Analysis (%)
6.5. Corticosteriods
6.6. Medical Cannabis Treatment
6.7. Menthol-Containing Treatment
6.8. Others

7. BY APPLICATION

7.1. Introduction
7.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
7.3. Market Attractiveness Index, By Application
7.4. Orthopedic and Musculoskeletal Pain
  7.4.1. Introduction
  7.4.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), 2018-2026
7.5. Neuropathic Pain
7.6. Cancer Pain
7.7. Other Pain

8. BY REGION

8.1. Introduction
8.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Region
8.3. Market Attractiveness Index, By Region
8.4. North America
  8.4.1. Introduction
  8.4.2. Key Region-Specific Dynamics
  8.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Drug Type
  8.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
  8.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
    8.4.5.1. U.S.
    8.4.5.2. Canada
    8.4.5.3. Mexico
8.5. Europe
  8.5.1. Introduction
  8.5.2. Key Region-Specific Dynamics
  8.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Drug Type
  8.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
  8.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
    8.5.5.1. Germany
    8.5.5.2. The U.K.
    8.5.5.3. France
    8.5.5.4. Italy
    8.5.5.5. Spain
    8.5.5.6. Rest of Europe
8.6. South America
  8.6.1. Introduction
  8.6.2. Key Region-Specific Dynamics
  8.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Drug Type
  8.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
  8.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
    8.6.5.1. Brazil
    8.6.5.2. Argentina
    8.6.5.3. Rest of South America
8.7. Asia Pacific
  8.7.1. Introduction
  8.7.2. Key Region-Specific Dynamics
  8.7.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Drug Type
  8.7.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
  8.7.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
    8.7.5.1. China
    8.7.5.2. India
    8.7.5.3. Japan
    8.7.5.4. Australia
    8.7.5.5. Rest of Asia Pacific
8.8. The Middle East and Africa
  8.8.1. Introduction
  8.8.2. Key Region-Specific Dynamics
  8.8.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Drug Type
  8.8.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application

9. GLOBAL MARKET – COMPETITIVE LANDSCAPE

9.1. Competitive Scenario
9.2. Competitor Non-Opioid Pain Treatment Strategy Analysis
9.3. Comparative Product Portfolio Analysis
9.4. Market Positioning/Share Analysis
9.5. Mergers and Acquisitions Analysis

10. COMPANY PROFILES

10.1. Aphria Inc. *
  10.1.1. Company Overview
  10.1.2. Product Portfolio and Description
  10.1.3. Key Highlights
  10.1.4. Financial Overview
10.2. Aurora
10.3. Bedrocan
10.4. Canopy Growth Corp.
10.5. Cara Therapeutics
10.6. Centrexion Therapeutics
10.7. Cronos Group
10.8. GW Pharmaceuticals
10.9. Medical Marijuana Inc.
10.10. Medropharm Gmbh
10.11. Panag Pharma Inc.
10.12. Tilray
10.13. US Worldmeds LLC
10.14. Vanway

11. DATAM INTELLIGENCE

11.1. Appendix
11.2. About Us and Services
11.3. Contact Us